{"type":"rich","version":"1.0","provider_name":"Transistor","provider_url":"https://transistor.fm","author_name":"Our Curious Amalgam","title":"#398 What's 340B? An Economist's View of the Recent Wave of 340B Litigation","html":"<iframe width=\"100%\" height=\"180\" frameborder=\"no\" scrolling=\"no\" seamless src=\"https://share.transistor.fm/e/da47b45e\"></iframe>","width":"100%","height":180,"duration":1635,"description":"The Federal 340B Drug Pricing Program has grown from a modest drug discount program into a massive federal program involving pharmaceutical manufacturers, hospitals, pharmacies, insurers, and third-party administrators. But when can similar conduct by...","thumbnail_url":"https://img.transistorcdn.com/Z_uzRhDx3vU4Ynp2Y5bEX_3uqrFgy-uNcxY7NsSzt7o/rs:fill:0:0:1/w:400/h:400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9lZWZh/MTZhNDBhMDJlZmZm/Mjc3OWEzMzYzNDUz/MjAwNy5qcGc.webp","thumbnail_width":300,"thumbnail_height":300}